Navigation Links
Prestigious fellowship for young Nottingham researcher
Date:2/3/2009

A promising young researcher at The University of Nottingham has been awarded a prestigious national fellowship to support her work investigating the molecular biology of hepatitis C virus.

Dr Catherine Jopling, of the University's School of Pharmacy, has received more than 1 million in funding over five years from a David Phillips fellowship given by the Biotechnology and Biological Sciences Research Council (BBSRC).

Dr Jopling said: "I'm delighted to have been awarded this fellowship. It will be enormously helpful in allowing me to set up my own group and to pursue this exciting research."

The fellowship will cover her salary and provide research funding to allow her to continue with work started while a postdoctoral researcher at Stanford University in the US looking at micro-RNAs, tiny molecules that play a major part in controlling gene expression in cells.

Dr Jopling's research focuses on miR-122, a specialised liver microRNA which interacts with hepatitis C virus (HCV) in an unusual way and plays an important role in helping the virus to replicate itself, an essential part of the viral life cycle.

Hepatitis C is a blood-borne infectious disease which currently affects around two per cent of the population. The infection can go undetected for a long period of time because it often produces no or few symptoms but as the disease becomes more chronic it can lead to serious scarring of the liver (cirrhosis) and even cancer.

Dr Jopling's research looking at how HCV hijacks miR122 to help in its attack on the liver has been recognised by the BBSRC because of the important role it plays in developing our understanding of gene expression and the basic biology of microRNA activity. In the future, the work may also have implications for medical advances if more can be understood about the process by which HCV replicates and spreads, new drugs which act by blocking this action could be developed to help halt the progression of the disease.

The BBSRC awards six to 10 David Phillips fellowships a year to young scientists who have shown huge potential in their early research work and allows them to become well established in their chosen field.

Dr Jopling carried out her PhD from 1998-2001 at the University of Leicester, before obtaining a Wellcome Trust International Research Fellowship, which allowed her to work as a postdoctoral researcher at Stanford University. The fellowship provided a further year of funding to return to a UK-based lab and she spent a year working at the University of Cambridge. She joined Nottingham in 2007 as part of the RNA Biology Group in the School of Pharmacy.


'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Related medicine news :

1. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
4. Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
5. Jerry Lewis to Receive Prestigious Award From Motion Picture Academy
6. Arthritis Foundation bestows prestigious national research award
7. Organogenesis Receives Two Prestigious Awards for Economic Impact and Manufacturing Excellence
8. Melissa Murer Corrigan Receives Prestigious NOCA Leadership Award
9. Capital BlueCross Receives Prestigious Corporation of the Year Award
10. U of T professor first Canadian woman to win prestigious international science prize
11. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... , ... May 27, 2017 , ... Most us are ... but a new study from the Osteoarthritis Initiative shows that certain people ... osteoarthritis. Knowing this in advance may give doctors the opportunity to treat patients before ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CEO 2017 on May 30th and 31st at The Four Seasons Hotel Boston. ... executives in the life sciences, offering exclusive access to key decision makers who ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... Nevada (PRWEB) , ... May 26, 2017 , ... ... produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically designed ... conference applications. “We are thrilled to partner with Cupron® to provide customers ...
(Date:5/26/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... being discussed by President Donald Trump and the rest of the world. Donald Trump ... peace talks in the continuous battle between Israel and Palestine. The world’s eyes are ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Radiology has become the number one diagnostic ... spiraled to the number one ranking as a result.  ... before as the most complete and reliable method for ... back pain an MRI may confirm a suspected herniated ... in entirely different treatment protocols.  In these circumstances, patients ...
(Date:5/9/2017)... Ore. , May 9, 2017  Semler ... that provides technology solutions to improve the clinical ... financial results for the first quarter ended March ... our products enable our customers to identify when ... to intervene before events like heart attacks or ...
(Date:5/6/2017)... , May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: ... approximately 100,000 square feet to its Welch Allyn campus. ... its commitment to bring more than 100 new jobs ... Welch Allyn has maintained a significant presence for more ... these new positions, a large portion of which will ...
Breaking Medicine Technology: